Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Array Withdraws NDA for Anticancer Drug Binimetinib

Array BioPharma reported over the weekend that it is withdrawing its NDA for approval of binimetinib (MEK162) monotherapy in ...

Forward this item to a colleague:

(Separate multiple addresses by commas)